Publications by authors named "Paul Dranichnikov"
Background: Long-term survival for selected patients with peritoneal metastases (PM) from colorectal cancer (CRC) is possible when treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The objective of this study was to compare three different oxaliplatin-based (OX)-HIPEC regimens. Primary end-point was disease-free survival (DFS), and secondary endpoints, morbidity and overall survival (OS).
View Article and Find Full Text PDFArticle Synopsis
- The study examines coagulation changes in patients post cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to understand their relationship with venous thromboembolism (VTE).
- It analyzed various coagulation biomarkers in 380 patients over 10 days after surgery, finding that certain biomarkers like D-dimer and tumor presence were linked to VTE risk.
- The research concluded that although significant changes in coagulation markers occur post-op, the actual incidence of VTE was low, with specific factors indicating risk levels.
Background: Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC.
Methods: The national in-hospital patient register was used to identify patients via the HIPEC ICD code JAQ10 2004-2014.